1. Home
  2. CNTB

CNTB

Connect Biopharma Holdings Limited

Logo Connect Biopharma Holdings Limited

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Founded: 2012 Country:
China
China
Employees: N/A City: N/A
Market Cap: 105.7M IPO Year: 2021
Target Price: $6.50 AVG Volume (30 days): 165.2K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.15 EPS Growth: N/A
52 Week Low/High: $0.54 - $2.84 Next Earning Date: 04-30-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 305.78%

Share on Social Networks: